2 files

Ngoc Do_Venetoclax plus Obinutuzumab vs Chlorambucil plus Obinutuzumab_Cost-Effectiveness Analysis Model.xlsm

Download all (6.4 MB)
Version 3 2022-06-30, 15:59
Version 2 2022-01-21, 02:01
Version 1 2022-01-21, 01:57
posted on 2022-06-30, 15:59 authored by Ngoc DoNgoc Do, Frederick ThielenFrederick Thielen
The excel model details all the assumptions, data inputs, data sources, and data analysis codes used to output the results represented in our article titled: "Cost-effectiveness of Venetoclax plus Obinutuzumab versus Chlorambucil plus Obinutuzumab for the first-line treatment of adult patients with chronic lymphocytic leukemia - an extended social view."

Please see the Data appendix file to view detailed description of the model.